Physician profile
Christa Johnson
NPI 1356364012
$953.61
in general payments reported to CMS, 2019-2025
18 companies · $152 in 2025
The $152 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $142 · 2021: $36.60 · 2022: $16.95 · 2023: $120 · 2024: $224 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.26 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $115.24 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $96.24 | 2019-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Tris Pharma INC | $90.96 | 2019-2024 | Dyanavel Xr |
| Vertical Pharmaceuticals, LLC | $75.84 | 2019-2025 | Relexxii |
| Corium, LLC | $72.73 | 2024-2025 | Azstarys |
| Sanofi Pasteur INC. | $55.88 | 2019-2023 | |
| Pfizer INC. | $48.68 | 2024 | |
| Collegium Pharmaceutical, INC. | $43.49 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $33.99 | 2020-2023 | Bexsero |
| Bard Peripheral Vascular, INC. | $33.88 | 2019 | |
| Neos Therapeutics, Lp | $31.91 | 2019-2020 | |
| Seqirus USA INC | $31.35 | 2023 | Flucelvax Quadrivalent |
| Takeda Pharmaceuticals U.S.A., INC. | $28.01 | 2019 | |
| Adlon Therapeutics L.P. | $24.57 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $21.89 | 2024 | Auvi-Q |
| Supernus Pharmaceuticals, INC. | $19.57 | 2025 | Qelbree |
| Shire North American Group INC | $14.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christa Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.